Challenges in the transition to model-based development

AAPS Journal

Volumn 7, Issue 2, 2005, Pages

  Grasela, Thaddeus H ^a   Fiedler Kelly, Jill ^a   Walawander, Cynthia A ^a   Owen, Joel S ^a   Cirincione, Brenda B ^a   Reitz, Kathleen E ^a   Ludwig, Elizabeth A ^a   Passarell, Julie A ^a   Dement, Charles W ^b  

^a Albany Medical College   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Model based development; Pharmacometrics; Real time data assembly

Indexed keywords

ARTICLE; ATTITUDE TO CHANGE; CULTURAL FACTOR; DATA ANALYSIS; DECISION MAKING; DRUG RESEARCH; HUMAN; INFORMATION PROCESSING; ORGANIZATION; PERFORMANCE; PERSONNEL MANAGEMENT; PRACTICE GUIDELINE; PROCESS DESIGN; PROCESS DEVELOPMENT; PROCESS MODEL; SIMULATION; STAFF TRAINING; TEAMWORK;

ANIMALS; HUMANS; MODELS, THEORETICAL; PHARMACOKINETICS; TECHNOLOGY, PHARMACEUTICAL;

EID: 30444434228     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070249     Document Type: Article

References (10)

1. Grasela TH, Sheiner LB. Population pharmacokinetics of procainamide from routine clinical data. Clin Pharmacokinet. 1984;9:545-554.
2. Beal SL, Sheiner LB, eds. NONMEM Users Guides. San Francisco: University of California at San Francisco; 1998.
3. U.S. Department of Health and Human Services. Challenge and Opportunity on the Critical Path to New Medical Products. Washington, DC: Food and Drug Administration; 2004.
4. Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther. 1997;61:275-291.
5. Data on file. Cognigen Corporation, 395 Youngs Rd, Buffalo, NY 14221.
6. Antal EJ, Grasela TH Jr, Smith RB. An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly. Clin Pharmacol Ther. 1989;46:552-559.
7. Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH Jr. Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm Res. 1997;14:91-97.
8. Grasela TH, Antal EJ, Fiedler-Kelly J, et al. An automated drug concentration screening and quality assurance program for clinical trials. Drug Inf J. 1999;33:273-279.
9. FDA. Guidance for Industry: Population Pharmacokinetics. Washington, DC: Food and Drug Administration; 1999.
10. Stewart JJ, Allison PN, Johnson RS. Putting a price on biotechnology. Nature Biotechnology. 2001;19:813-817.